OA11246A - Gelatine encapsulated solution dosage forms of sertraline - Google Patents

Gelatine encapsulated solution dosage forms of sertraline Download PDF

Info

Publication number
OA11246A
OA11246A OA9900306A OA9900306A OA11246A OA 11246 A OA11246 A OA 11246A OA 9900306 A OA9900306 A OA 9900306A OA 9900306 A OA9900306 A OA 9900306A OA 11246 A OA11246 A OA 11246A
Authority
OA
OAPI
Prior art keywords
sertraline
dosage form
mga
oil
vehicle
Prior art date
Application number
OA9900306A
Other languages
English (en)
Inventor
William John Curatolo
Ravi Mysore Shanker
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA11246(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of OA11246A publication Critical patent/OA11246A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
OA9900306A 1997-07-01 1999-12-23 Gelatine encapsulated solution dosage forms of sertraline OA11246A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5140197P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
OA11246A true OA11246A (en) 2002-11-19

Family

ID=21971076

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900306A OA11246A (en) 1997-07-01 1999-12-23 Gelatine encapsulated solution dosage forms of sertraline

Country Status (40)

Country Link
EP (1) EP0980241B1 (de)
JP (1) JP3585245B2 (de)
KR (1) KR100371730B1 (de)
CN (1) CN1261792A (de)
AP (1) AP945A (de)
AR (1) AR015916A1 (de)
AT (1) ATE256457T1 (de)
AU (1) AU724635B2 (de)
BG (1) BG103917A (de)
BR (1) BR9809712A (de)
CA (1) CA2290973C (de)
CO (1) CO4940405A1 (de)
DE (1) DE69820608T2 (de)
DK (1) DK0980241T3 (de)
DZ (1) DZ2544A1 (de)
EA (1) EA001905B1 (de)
ES (1) ES2210760T3 (de)
GT (1) GT199800090A (de)
HR (1) HRP980378B1 (de)
HU (1) HUP0002250A3 (de)
ID (1) ID24673A (de)
IL (1) IL133075A0 (de)
IS (1) IS5266A (de)
MA (1) MA24586A1 (de)
MY (1) MY119728A (de)
NO (1) NO996492L (de)
NZ (1) NZ501252A (de)
OA (1) OA11246A (de)
PA (1) PA8454001A1 (de)
PE (1) PE97299A1 (de)
PL (1) PL337807A1 (de)
PT (1) PT980241E (de)
SK (1) SK282914B6 (de)
TN (1) TNSN98123A1 (de)
TR (1) TR199903282T2 (de)
TW (1) TW382597B (de)
UA (1) UA68350C2 (de)
UY (1) UY25070A1 (de)
WO (1) WO1999001113A1 (de)
ZA (1) ZA985709B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
WO2000021521A2 (en) * 1998-10-13 2000-04-20 Pfizer Products Inc. Sertraline oral concentrate
PL211402B1 (pl) 1999-09-03 2012-05-31 Apbi Holdings Zastosowanie dapoksetyny do leczenia lub zwalczania przedwczesnej ejakulacji
MXPA03001771A (es) 2000-08-30 2003-06-04 Pfizer Prod Inc Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento.
EP1375659A1 (de) * 2002-06-18 2004-01-02 Laboratorio di Diagnostica Moleculare Konzentratmischungen in löslichen Kapseln zur einfachen Zubereitung von chemischen oder biologischen Lösungen
EP1556000A1 (de) * 2002-10-31 2005-07-27 Alza Corporation Pharmazeutische formulierung zur erhöhten bioverfügbarkeit hydrophober arzneistoffe
WO2016020936A2 (en) * 2014-07-21 2016-02-11 Patel Jayendrakumar Dasharathlal A novel oral gastroretentive pharmaceutical dosage form
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法
GB2630572A (en) 2023-05-29 2024-12-04 Novumgen Ltd An orally disintegrating tablet of sertraline and its process of preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE214276T1 (de) * 1994-09-19 2002-03-15 Du Pont Pharm Co Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
EP0768083B1 (de) * 1995-07-17 2003-03-26 Pfizer Inc. Sertralin zur Behandlung von Post-Myocard-Infarkt-Patienten

Also Published As

Publication number Publication date
EA001905B1 (ru) 2001-10-22
KR100371730B1 (ko) 2003-02-07
NO996492L (no) 2000-02-29
WO1999001113A1 (en) 1999-01-14
PL337807A1 (en) 2000-09-11
IS5266A (is) 1999-11-23
EA199900963A1 (ru) 2000-08-28
BR9809712A (pt) 2000-07-11
NO996492D0 (no) 1999-12-27
KR20010013588A (ko) 2001-02-26
SK180599A3 (en) 2001-01-18
CA2290973C (en) 2003-06-17
ES2210760T3 (es) 2004-07-01
EP0980241A1 (de) 2000-02-23
PT980241E (pt) 2004-03-31
HRP980378A2 (en) 1999-04-30
TR199903282T2 (xx) 2000-08-21
JP2000512316A (ja) 2000-09-19
PA8454001A1 (es) 2000-05-24
EP0980241B1 (de) 2003-12-17
CO4940405A1 (es) 2000-07-24
CA2290973A1 (en) 1999-01-14
AP945A (en) 2001-02-28
AU724635B2 (en) 2000-09-28
TNSN98123A1 (fr) 2005-03-15
AP9801279A0 (en) 1998-06-30
NZ501252A (en) 2004-11-26
IL133075A0 (en) 2001-03-19
MA24586A1 (fr) 1998-12-31
ID24673A (id) 2000-07-27
SK282914B6 (sk) 2003-01-09
TW382597B (en) 2000-02-21
ZA985709B (en) 2000-01-10
ATE256457T1 (de) 2004-01-15
DZ2544A1 (fr) 2003-02-08
DK0980241T3 (da) 2004-04-05
AU7545098A (en) 1999-01-25
DE69820608T2 (de) 2004-12-23
HUP0002250A2 (hu) 2000-12-28
DE69820608D1 (de) 2004-01-29
HRP980378B1 (en) 2001-12-31
MY119728A (en) 2005-07-29
PE97299A1 (es) 1999-10-13
UY25070A1 (es) 2000-12-29
UA68350C2 (en) 2004-08-16
JP3585245B2 (ja) 2004-11-04
GT199800090A (es) 1999-12-21
HUP0002250A3 (en) 2001-01-29
CN1261792A (zh) 2000-08-02
BG103917A (bg) 2000-07-31
AR015916A1 (es) 2001-05-30

Similar Documents

Publication Publication Date Title
AU718052B2 (en) Intestinal absorption of nicotine to treat nicotine responsive conditions
US5431916A (en) Pharmaceutical compositions and process of manufacture thereof
US5391377A (en) Biphasic release formations for lipophilic acids
US7115565B2 (en) Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
AU718971B2 (en) Colonic delivery of nicotine to treat inflammatory bowel disease
BRPI0008228B1 (pt) composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes
AU724635B2 (en) Gelatine encapsulated solution dosage forms of sertraline
JP2004520398A (ja) 経口生物学的利用能が改善されたパクリタキセルの化学療法マイクロエマルジョン組成物
CA3140113A1 (en) Self-emulsifying cannabidiol formulations
US20030133974A1 (en) Encapsulated solution dosage forms of sertraline
US4699776A (en) Suppositories containing analgesics, antipyretics or anti-inflammatory agents
MXPA99012099A (en) Gelatine encapsulated solution dosage forms of sertraline
US20160000734A1 (en) Method and compositions of civamide to treat disease of the intestines
HK1028882A (en) Gelatine encapsulated solution dosage forms of sertraline
CZ464299A3 (cs) Želatinové zapouzdření roztokové dávkovači formy sertralinu
EP4684775A1 (de) Orale lösung mit nitrazepam